BDBM752391 (1R,3S,5R)-2-(2-(11-acet- yl-3-methylpyrimido [4'',5'':6,7]cyclohepta[1,2- f]indazol-9(7H)-yl)acetyl)- N-(6-bromo-3-methylpyr- idin-2-yl)-5-methyl-2-aza- bicyclo[3.1.0]hexane-3- carboxamide::US20250197403, Compound 69

SMILES CC(=O)c1nn(CC(=O)N2[C@H](C(=O)Nc3nc(Br)ccc3C)C[C@@]3(C)C[C@@H]23)c2cc3c(cc12)-c1cnc(C)nc1C=CC3

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752391   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752391((1R,3S,5R)-2-(2-(11-acet- yl-3-methylpyrimido [4',...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent